[go: up one dir, main page]

SE9401480D0 - A new 78 residue polypeptide (NK-lysine) and its use - Google Patents

A new 78 residue polypeptide (NK-lysine) and its use

Info

Publication number
SE9401480D0
SE9401480D0 SE9401480A SE9401480A SE9401480D0 SE 9401480 D0 SE9401480 D0 SE 9401480D0 SE 9401480 A SE9401480 A SE 9401480A SE 9401480 A SE9401480 A SE 9401480A SE 9401480 D0 SE9401480 D0 SE 9401480D0
Authority
SE
Sweden
Prior art keywords
pct
polypeptide
sec
date
lysine
Prior art date
Application number
SE9401480A
Other languages
English (en)
Other versions
SE502670C2 (sv
SE9401480L (sv
Inventor
Hans Joernvall
Hans G Boman
Viktor Mutt
Mats Andersson
Original Assignee
Hans Joernvall
Hans G Boman
Viktor Mutt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hans Joernvall, Hans G Boman, Viktor Mutt filed Critical Hans Joernvall
Priority to SE9401480A priority Critical patent/SE502670C2/sv
Publication of SE9401480D0 publication Critical patent/SE9401480D0/sv
Priority to EP95918245A priority patent/EP0753012A1/en
Priority to US08/732,228 priority patent/US5981469A/en
Priority to PCT/SE1995/000475 priority patent/WO1995029937A1/en
Priority to JP7528154A priority patent/JPH09512546A/ja
Priority to AU24236/95A priority patent/AU2423695A/en
Publication of SE9401480L publication Critical patent/SE9401480L/sv
Publication of SE502670C2 publication Critical patent/SE502670C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE9401480A 1994-04-29 1994-04-29 En ny 78-resters polypeptid (NK-lysin) och dess användning SE502670C2 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE9401480A SE502670C2 (sv) 1994-04-29 1994-04-29 En ny 78-resters polypeptid (NK-lysin) och dess användning
EP95918245A EP0753012A1 (en) 1994-04-29 1995-04-28 A new 78 residue polypeptide (nk-lysine) and its use
US08/732,228 US5981469A (en) 1994-04-29 1995-04-28 78 residue polypeptide (NK-lysine) and its use
PCT/SE1995/000475 WO1995029937A1 (en) 1994-04-29 1995-04-28 A new 78 residue polypeptide (nk-lysine) and its use
JP7528154A JPH09512546A (ja) 1994-04-29 1995-04-28 新規な７８残基ポリペプチド（ｎｋ−リジン）およびその使用
AU24236/95A AU2423695A (en) 1994-04-29 1995-04-28 A new 78 residue polypeptide (nk-lysine) and its use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9401480A SE502670C2 (sv) 1994-04-29 1994-04-29 En ny 78-resters polypeptid (NK-lysin) och dess användning

Publications (3)

Publication Number Publication Date
SE9401480D0 true SE9401480D0 (sv) 1994-04-29
SE9401480L SE9401480L (sv) 1995-10-30
SE502670C2 SE502670C2 (sv) 1995-12-04

Family

ID=20393838

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9401480A SE502670C2 (sv) 1994-04-29 1994-04-29 En ny 78-resters polypeptid (NK-lysin) och dess användning

Country Status (6)

Country Link
US (1) US5981469A (sv)
EP (1) EP0753012A1 (sv)
JP (1) JPH09512546A (sv)
AU (1) AU2423695A (sv)
SE (1) SE502670C2 (sv)
WO (1) WO1995029937A1 (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6485928B2 (en) * 1997-11-04 2002-11-26 The Board Of Trustees Of The Leland Stanford Junior University Use of granulysin as an antimicrobial agent
AU2005100473B4 (en) * 2005-06-03 2005-07-14 Rheem Australia Pty Limited Water heater

Also Published As

Publication number Publication date
WO1995029937A1 (en) 1995-11-09
SE502670C2 (sv) 1995-12-04
JPH09512546A (ja) 1997-12-16
SE9401480L (sv) 1995-10-30
AU2423695A (en) 1995-11-29
EP0753012A1 (en) 1997-01-15
US5981469A (en) 1999-11-09

Similar Documents

Publication Publication Date Title
MX9705954A (es) Formulaciones y metodos para reducir irritacion de la piel.
TW376319B (en) Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
IL112111A0 (en) Peptide derivatives and pharmaceutical compositions containing them
AU3357800A (en) Method of preparing alkylated salicylamides
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
MY119350A (en) Propiophenone derivatives and process for preparing the same
MX9705710A (es) Compuestos con propiedades de liberacion de la hormona del crecimiento.
NO952321L (no) Polypeptid, samt anti-HIV-preparat fremstilt fra dette
PL319833A1 (en) Compounds and composition for carrying active media
UA65561A (en) Therapeutic agent for lymphatic tumors
CA2296036A1 (en) Dolastatin 15 derivatives
SE9101838D0 (sv) Novel peptides and their use
AU4363199A (en) Use of hmg proteins for the preparation of medicaments having cytotoxic activity
AU1031697A (en) Novel geranylgeranyl-derivatives, process for the preparation thereof and related pharmaceutical compositions
LV10108A (lv) Sunu proliferacijas inhibitori farmaceitiska kompozicija savienojumu iegusanas metode sunu proliferacijas inhibesanas panemieni
GR3020330T3 (en) Novel bicyclic pyrimidine compounds, method for preparing same and pharmaceutical compositions containing said compounds.
GR3030947T3 (en) Selective system scan for multizone radiotelephone subscriber units.
BG105204A (en) Salts of paroxetine
SE9401480D0 (sv) A new 78 residue polypeptide (NK-lysine) and its use
SE9403055D0 (sv) A new human peptide antibiotic (FALL-39) and its use
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
EP1074264A4 (en) NEOVASCULARIZATION INHIBITORS
HK1008225A1 (en) Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone
NZ503027A (en) Use of rifamycin derivative for treating mastitis in a domestic animal
MX9800686A (es) Nueva proteina hmw humana mp52s.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 9401480-0

Format of ref document f/p: F